Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Toggle Search Area
Toggle Menu
e-mail Print Share

FDA Awards $1.5 Million Grant to ADA Science and Research Institute

ADASRI, University of Pittsburgh to develop pain management guidelines in dentistry with focus on role of opioids

August 28, 2020

Contact Information:

CHICAGO, August 28, 2020 — The American Dental Association (ADA) announced today that the U.S. Food & Drug Administration has awarded a three-year, $1.5 million grant to the ADA Science & Research Institute, LLC (ADASRI) in collaboration with the University of Pittsburgh to develop a clinical practice guideline for the management of acute pain in dentistry with a focus on the role of opioids.

“The ADA has long been committed to providing the best possible information about managing acute pain for patients, including focusing on further defining the role of opioids in dentistry,” said Marcelo Araujo, D.D.S., M.S., Ph.D., chief executive officer, ADA Science & Research Institute. “This project will improve clinician and patient access to the evidence and recommendations for all dental specialties, and will serve key stakeholder groups throughout guideline development.”

ADASRI will work with the University of Pittsburgh to develop, disseminate, implement, and evaluate a national clinical practice guideline for the management of acute pain in dentistry. Alonso Carrasco-Labra, D.D.S., M.Sc., Ph.D., senior director of ADASRI Evidence Synthesis & Translation Research, and Deborah Polk, Ph.D., assistant professor of dental public health in the School of Dental Medicine at the University of Pittsburgh, will serve as the project’s co-principal investigators.

“As a part of the recently founded ADA Science & Research Institute, I believe that this project reflects the strong commitment of ADASRI to conduct research on topics of great importance for the public and the dental profession,” said Dr. Carrasco-Labra. “This award aligns with ADA’s strong commitment toward optimal, evidence-based management of acute pain in dentistry, including the use of opioids.”

This is the first grant awarded to ADASRI’s Evidence Synthesis & Translation Research team since the official launch of ADASRI in January 2020. This award adds to the growing list of ADASRI grant awards for 2020, which also includes three National Institutes of Health (NIH) grants awarded to the ADASRI Innovation & Technology Research team.

For more information on how the ADA is working to combat opioid abuse, while continuing to help patients manage dental pain, visit For more information on ADASRI, visit

Editor’s Note: Reporters are invited to follow the ADA on Twitter @AmerDentalAssn


About the ADA

The not-for-profit ADA is the nation's largest dental association, representing 163,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The monthly The Journal of the American Dental Association (JADA) is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA's consumer website

About the ADA Science & Research Institute, LLC
ADASRI was created in January 2020 as an LLC subsidiary of the American Dental Association to oversee and manage all ADA science and research programs. ADASRI comprises three departments — Evidence Synthesis & Translation Research, Innovation & Technology Research, and Research & Laboratories — whose collective mission is “improving lives through oral health, science, and research.” For more information, visit